Login to Your Account



Other News To Note


Wednesday, January 19, 2011
Curefaktor Pharmaceuticals LLC, of Buffalo, N.Y., received orphan drug designation from the FDA for lead compound CFAK-C4 in pancreatic cancer.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription